Joseph Vittiglio
CIK 1551776 · Chief Business & Legal Officer · last filed 2026-03-02
Joseph Vittiglio is a Chief Business & Legal Officer who has filed 36 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for PEPG, was dated Mar 2, 2026. Across all open-market trades the lifetime net is −$83.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $158.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$158.4K
5
36
-$83.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PEPG | Chief Business & Legal Officer | 65,717 | $2.41 | $158.4K | $0 | 2 | 2026-03-02 |
| bluebird bio, Inc. (BLUE) Delisted | Chief Business & Legal Officer | 3,125 | $4.97 | $15.5K | -$6.5K | 6 | 2025-06-03 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Chief Business & Legal Officer | 1,045 | $7.30 | $7.6K | -$5.1K | 4 | 2022-10-25 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Chief Business Officer, GC | 0 | — | — | -$56.9K | 17 | 2020-11-17 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | SVP, General Counsel | 2,092 | $15.00 | $31.4K | -$15.5K | 5 | 2015-01-08 |
Recent Filings
36 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-02 | PEPG | Grant (A) | +30,717 | $0 | EDGAR |
| 2025-12-10 | PEPG | Grant (A) | +35,000 | $0 | EDGAR |
| 2025-06-03 | bluebird bio, Inc. (BLUE) Delisted | Mixed | −4,268 | $0 | EDGAR |
| 2025-02-05 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −238 | -$1.8K | EDGAR |
| 2025-02-03 | bluebird bio, Inc. (BLUE) Delisted | Notice (144) | −238 | -$1.8K | EDGAR |
| 2024-10-02 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2024-03-05 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-06 | bluebird bio, Inc. (BLUE) Delisted | Sell (S) | −5,217 | -$4.7K | EDGAR |
| 2023-02-03 | bluebird bio, Inc. (BLUE) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2022-10-25 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Sell (S) | −3,636 | -$5.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.